第四节 载脂蛋白CⅢ基因型检测
载脂蛋白CⅢ基因位于11号染色体与载脂蛋白AⅠ-AⅣ形成一基因族，它位于载脂蛋白AⅠ下游，有三个内含子和四个外显子。目前对载脂蛋白CⅢ基因3'末端非编码区C-G对换产生一个Sac-Ⅰ酶切位点与冠心病的关系未有定论。用多聚酶链反应(PCR)扩增载脂蛋白CⅢ基因3'末端233bp，再用Sac-1酶切扩增产物，可以检测载脂蛋白CⅢ基因3'末端的突变及其与动脉粥样硬化相关性。本节采用PCR-RFLP检测ApoCⅢ基因型。
一、仪器与试剂
1.仪器：电泳仪，基因扩增仪。
2.试剂：TaqDNA聚合酶，dNTP，DNA参考物，Sca-1酶。
二、操作方法
1.模DNA提取
取用EDTA抗凝全血100μl加试剂(0.32mol/L蔗糖，5mmol/L MgCl2,1% TritonX-100,0.01mol/L Tris-HClpH7.6)，振摇至溶解均匀透明，3000r/min离心10min,弃上清，沉淀部分加0.9NaCl溶液洗一次，加预冷试剂Ⅱ(75mmol/L NaCl,24mmol/L EDTA)100μl，20%SDS15μl，蛋白酶K10μl(6g/L)于65℃水浴4h，加200μl酚和氯仿：异戊醇(24：1)各提两次，上清加无水乙醇1.0ml放置于-20℃2h，以12kr/min离心5min，真空干燥后加50μlTE缓冲液溶解，4℃保存备用。
2.多聚酶链反应
Primer1：5'-GTG ACC GAT GGC TTC AGT TCC CTG-3'，primer2:5'-GGT AGG AGA GCA CTC AGA ATA CA-3'。反应总体积为50μl，扩增缓冲液所含物质终浓度为：Tris-HCl，pH8.3，67mmol/L；MgCl2 25mmol/L；KCl 50mmol/L；明胶0.01%，dNTP各0.2～0.5μmol/L，模板约10μg，加40μl液体石蜡，94℃预变性4min，加Tag聚合酶1.5U，以93℃1min、65℃1.5min、72℃1.5min，循环30次。
3.扩增产物酶切
取扩增产物20μl加入NH4AC20μl，再加300μl无水乙醇混均置-20℃1h，10000r/min离心7min弃上清，干燥后加Sac-1酶液10μl37℃保温2h。
4.扩增产物碱基对分子量测定
采用GB公司产DNA marker,以已知DNA片段bp数相对应的电泳迁移距离，取半对数作图制成标准曲线，再根据等测定扩增产物DNA片段移动距离在标准曲线上求出其bp数。
三、结果分析
采用本节设计引物扩增产物为ApoCⅢ基因3'非编码区233bp，该产物经Sac-1酶切可出现三种结果；①酶切后仍为一条带，电泳迁移率未发生改变，为S1S1纯合子；②酶切后除原始带外又增加了两条带，查标准DNA marker曲线在158bp和75bp相同，为S2S2杂合子；③酶切后原始带消失，出现两条新带，其电泳迁移率与158bp和75bp相同，为S2S2纯合子。S2为扩增的基因产物中C-G对换增加一个酶切位点。
检查100名正常人中有S2杂合子28名，纯合子2名；68名冠心病人中S2杂合16名，纯合子4名，它们的频率变化见表(19-4)。S2基因频率两组间无明显差别。
表19-4 载脂蛋白CⅢ基因Sac-Ⅰ酶切频率表
| 级别 |
n |
基因型 |
频 率 | |||
S1S1 |
S1S2 |
S2S2 |
S1 |
S2 | ||
正常人 |
100 |
70 |
28 |
2 |
0.84 |
0.16 |
冠心病 |
68 |
48 |
16 |
4 |
0.82 |
0.176 |
X=0.079,p>0.05(两组比较)
(徐 琼)
参考文献
1.鄢盛恺，载脂蛋白(a)研究近况，国外医学临床生物化学与检验学分册，1996，7：38
2.Utermann,G.The,mysteries of lipoprotein(a).Science,1989,246:904
3.Utermann G,Menzel HJ,Kraft HG,et al.Lp(a)glycoprotein phenotypes ,inheritance and relation to Lp(a)lipoprotein concentratios in plasma.J Clin Invest,1987,80:458
4.Utermann G,Kraft HG,Menzel HJ,et al.Genetics of the quantitative Lp(a)lipoprotein trati.I.Relation to lp(a)glycoprotein phenotypes to Lp(a)lipoprotein concentrations in plasma.Hum Genet,1988,78:41
5.Kraft HG,Dieplinger ,Hoye E,et al.Lp(a)phenotyping by immunoblotting with polyclonal and monoclonal antibodies.Arteriosclerosis,1988,8:212
6.Huang CM,Kraft HG,Gregg RE,Modified immunoblotting technique for phenotyping lipoprotein (a),Clin Chem,1991,37:576
7.Gaubtz JW,Ghanem KI,Geavara J Jr,et al.Polymorphism of human apolipoprotein (a):Inhertance and relationship of their molecular weights to plasma levels of lipoprotein(a).Jlipid Res,1990,31:603
8.Kamboh MI ,Ferrell RE,Kottke BA.Expressed hypervariable polymorphism of apolipoprotein (a)Am J Hum Genet.1991,49:1063
9.Getoldi D,Bellotti V,Buscaglia P,et al .Characterization of Apo(a) polymorphism by a modified immunoblotting technique in an Italian poprlation sample.Clin Chim Acta,1993,221:159
10.Marcovina SM,Zhang ZH,Gaur VP,et al.Identification of 34 apolipoprotein (a)siofoms:differential expression of apolipoprotein(a) alleles between American blacks and whites.Biochem Biophys Res Commun,1993,191:1192
11.李建军，压一义，汪俊军，人血清脂蛋白(a)的多肽性检油，中华医学检测杂志，1994，17：22
12.Sandholzer C,boerwinkle E,Saha N,et al.Apolipoprotein(a) phenotypes,Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population ;evidence for the role of the Apo(a) gene in coronary heart disease.J Clin Invest,1992,89:1040
13.秦树存，王士雯，李成文等，载脂蛋白(a)多态性与冠心病的关系，中健医学杂志，1995，75：588
14.庄一义，李建军，汪俊军，心脑血管疾病患者载脂蛋白(a)多态性研究，中华医学杂志，1995，75：149
15.Pedro-Botet J,Senti M,Auguet T,et al.Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a)concentration in paticnts with peripheral vascular disease .Atherosclerosis ,1993,104:87
16.Dieplinger H,Lackner,Lackner C,Kronenberg F,et al.Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).J Clin Invest,1993,91:397
17.Utermann G,Jaeschke M,Menzel J.Familialhyperlipoproteinemia type Ⅲ.Deficiencyof a specific paolipoprteins.FEBS Lett,1975,56:352
18.Rall SC Jr,Weisgraber KH,Mahley RW.Human apolipoprotein Eheterogeneity cysteine-arginine interchanges in the amino acid sequence of theApoE isoforms.J Bio L Chem ,1981,256:9077
19.Wardell MR,Suckling PA,Janus ED.Genetic variation in humanapolipoprotein E.J Lipid Res,1982,23:1174
20.Zannis VI,Breslow JL.Human very low density lipoproteinapolipoprotein isoprotein polymorphism is explained by genetic vartion and post-translationalmodifications.Biochemistry,1981,20:1033
21.Davignon J,Gregg RE,Sing CF.Apolipoprotein E polymorphismand atherosclerosis.Arteriosclerosis,1988,8:11
22.解用虹，何锦林，王克勤，载脂蛋白E异构体的分离及其表型测定，生物化学与生物物理学报，1987，19：272
23.王克勤，解用虹，何锦麟。中国人群(京津地区)载脂蛋白E基因多态性和表型分布的研究，生物化学杂志1988，4：274
24.Utemann G,Steinmetz A,Weber W.Genetic control of humanapolipoprotein E polymorphism:Comparison of one and two dimensional techniquesof isoprotein analysis. Hum Genet,1982,60:34
25.吕新跃，陈保生，薜红等。微量血清等电聚焦电泳及免疫印这类法测定人载脂蛋白E表型，中华医学检验杂志，1994，17：26
26.牛庆田，国汉帮，山村卓等，免疫印迹法测定血清载脂蛋白E的表型，中华医学检验杂志，1994，17：16
27.Havekes LM,De Knijff P,Beisiegel V,et al.Arapidmicromethod for apolipoprotein E phenotyping directly in serum.J LipidRes,1987,28:455
28.Kataoka,S,Paidi M,Howard BV,Simplified isoelectricfocusing/immunoblotting determination of apolipoprotein E phenotype.ClinChem,1944,40:11
29.Scana AM,Edelstein C.Solubility in aqueous solution ofethjenol of thems all molecular weight peptides of the serum VLDL and HDL.AnalBiochem,1971,44:576
30.Menzel HJ,Kladetsky RG ,Assmann G,Apoprotein Epolymorphismand coronary artery disease.Arteriosclerosis,1983,3:310
31.Siest G,Pillot T,Regis-Bailly A,et al .Apoliprotein E:Animportant gene and protein to follow in laboratory medicine.ClinChem,1995,41:1068
32.Yamamura T,Yamamoto A,Sumiyoshi T,et al.New mutants ofapolipoprotein E associated with atherosclerotic disease but not to type Ⅲhyperlipoproteinemia .J Clin Invest,1984,74:1229
33.Cumming AM,Robertson F.Polymorphism at the apolipoproteinElocus in relation to risk of coronary disease.Clin Genet ,1984,25:310
34.Sing CF.Davignon,J.Role of the apolipoprotein Epolymorphism in determing mormal plasma lipid and lipoprotein variation Am J HumGenet,1985,37:268
35.Borwinkle E,Visvkis S,Welsh D,et al.The use of measuredgenotype information in the analysis of quanitation phenotypes in man.Am J HumGenet.1987,27:567
36.Ehnholm C,Lukka M,Kuusi T,et Apolipoprotein E polymorphismin the Finish poprlation ;gene frequencies and relation to lipoproteinconcentrations.J Lipid Res,1986,27:227
37.Ghiselli G,Schaefer EJ,Zech LA,et al.Increased prevalenceof apolipoprotein E4,in type V hyper lipoproteinemia.J Clin Invest,1982,70:474
38.Utermann G.Apolipoprotein E polymorphism in healyty anddisease.Am Heart J,1987,113:433
39.Pedro-Botet J,Senti (a),triglyceride-rich lipoproteins andapolipoprotein E polymorphism.Stroke,1992,23:1556
40.Couderc R,Mahieuk F,Bailleul S,et al.Prevalence ofapolipoprotein E phenotypes in ischemic cerebrovascular disease:A case-controlstudy.Stroke,1993,24:661
41.Shimano H,Ishibashi S,Murase T,et al.Plasmaapolipoproteins in patients with multiinfarctdementia.Atherosclerosis,1989,79:257
42.Strittmatter WJ,Saunders AM,Schmechel D,etal.Apolipoprotein E:High-avdity blinding to beta-amyloid and increased frequencyof type 4 allele in late-ornset familial Alzheimer disease.Proc Natl Acad SciUSA,1993,90:1977
43.Schachter F,Faure-Delanef L,Guenot F,et al .Geneticassocations with human longevity at the AopE and ACE loci.Nat Gengt,1994,6:29
44.Shoulders CC,Ball MJ,Mann JI,et al.Genetic marder inapolipoprotein AI/CⅢgene complex associated with hypercholwseterlemia.Lancet,1986,11:1286
45.Ordovas J,Civeira F,Genest JJr,et al.Restriction fragmentlength polymorphisms of the apolipoproteins ,and premature coronarydisease.Atherosclerosis,1991,87:75
46.Yang CY,Gu ZW,Weng S,et al.Structure of apolipoproteinB—100 of human low density lipoproteins.Arteriosclerosis,1989,9:96-108
47.Boerwinkle E,lee SS,Balter R et al.Rapid typing ofapolipoprotein B DNA polymorphism by DNAamplification.Atherosclerosis,1990,81:115-232
48.Soria LF,Ludwig EH ,Clarke HRG,et al.Association between aspecific apolipoprotein B mutation and familial defective apoprotein B-100 ProNatl Acad Sci USA,1989,96:587-591
49.Priestley,Knott T,Wallis S,et al.RFLP for the humamapolipoprotein B gene V:Xba I,Nucleic Acids Res,1985,13:6793
50.Wu H,Wen MS,Lo SK,et al.DNA polymorphisms ofapolipoprotein Bin the population of Taiwan.J Formos Med Assoc,1993,92:330-335
51.Young SG,Recent progress in understandingapolipoproteinB,Circulation,1990,82:1574-1579
52.Boerwinkle E,Xiong W.Fourest E,et al Rapid typing oftandemly repeated hypervariable loci by the polymerase chain reaction:Application to the apolipoprotein B3 hypervariable region.Proc Natl Acad SciUSA 1989,86:212-216
53.Hixon JE,PK,McMahan CA,et al.The human apolipoprotein B3hypervariable region :detection of eight new alleles and comparisons of allelefrequencies in blcks and whites.Hum Genet,1993,91:475-479
54.Friele W,Ludwig EH,Paulweber B,et al.Hypervariability in aminisatellite3 of the apoipoprotein B gene in patients with coronary heartdisease compared with normal controls.J Lipid Res,1990,31:659-665
55.Borwinkle E,chan L.Athree codon insertion /deletionpolymorphism in the signal peptide region of the human apolipoprotein B genedirectly typed by the popymerade chain reaction Nucleic Acids Res,1989,17:4003
56.Wu JH,Wen MS,Lo SK,et al.Increased frequency ofapolipoprotein B signal peptede SP 24/24 in patents with coronary arterydisease.General allele surey in the population of Taiwan and comparison withcaucasians,Clin Genet,1994,45:250-254
57.Renges HH,Wile DB,Mckeigue DM,et al.Apolipoprotein B genepolymorphisms are associated with lipid levels in men of South Asiandescent.Atheroscleosis,1991,91:267-275
58.Peacock R,Dunning A,Hamsten A,et al.Apolipoprotein B genepolymorphisms,lipophisms ,lipoproteins and atherosclerosis:a study of youngmycardial infarction survivors and healyhy poprlation baseindivduals.Atherosclerosis,1992,92:151-164
59.Saha W,Tong MC,Tay JS,et al.DNA polymorphisms of theapolipoprotein B gene in Chinese artery disease patients ,ClinGenet,1992,42:164-170
60.Loparev VN,Cartas MA,Monken CE,et al.An efficient andsimple method of DNA extraction from whole bolod and cell line to identifyinfectious agents .J Virol Methods ,1991,34:105-112
61.周新，甘佩珍，杨香玖等，健康成人与Ⅱ型糖尿病人ApoE遗传表型，武汉大学学报生物工程专利，1990，109-112
62.涂建成，周新，哈黛文等，聚合酶链反应技术检测ApoE基因型，中国病理生理杂志，1997，65
63.况少青，金桦，陈保生等，高脂血症患儿载脂蛋白AI-CⅢ基因限制性片段长度多态性研究，中华医学检验杂志，1994，17：19-21
64.鄢盛恺，周新，哈黛文等，聚合酶链反应限制性片段长度多态性检测ApoE基因型，中华医学检验杂志，1997，20：28-31
校对时间：1999-12-22 马海茸
, http://www.100md.com